A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1
The anti-correlation of PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells suggests... read more
January 28, 2025
Tagged: immunotherapy
CDR3s and Renalase-1 Correlate with Increased Melanoma Survival
Our group has demonstrated that chemical complementarity between tumor resident, T-cell receptor, complementarity-determining region 3 (... read more
September 26, 2024
Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer
In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more
June 20, 2024
Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer
In this editorial, researchers delve into the immunotherapeutic challenges posed by the tumor microenvironment and... read more
November 16, 2023
Immunotherapy Response Predicted by Machine Learning & Gut Microbiomes
Researchers investigated common gut microbiome features of response among immunotherapy patients with different advanced-stage cancers.... read more
September 1, 2022
Epigenetics and Immunotherapy Combined Fights Rare Lymphoma
In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more
August 24, 2022
Behind the Study: Evaluations in TRAMP Prostate Cancer Model
Dr. Yves Chabu from the Department of Biological Sciences at the University of Missouri describes... read more
September 20, 2021
New Study: Nanoparticles Target Acute Myeloid Leukemia
Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting... read more
September 15, 2021